How a Dubai doctor on tea break comes to the rescue of a man suffering heart attack after collapsing near metro station
cardiac arrest
. Shervin Sasidharan, 36, had just stepped out of work and had just started to walk towards the metro station when the incident took place. His vision got blurred, his legs buckled, and he collapsed on the pavement.
Sasidharan was completely unconscious, and he was barely breathing, and he was probably moments away from death due to a cardiac arrest. Just then, Dr. Niraj Gupta, a specialist in interventional cardiology at NMC Royal Hospital in Dubai Investment Park (DIP), who was out on a quick tea break, rushed to help after he noticed a crowd around someone on the ground.
Gupta, who was across the street, said that the person (Sasidharan) had suffered a cardiac arrest and there was a need for quick action to save his life.
Recalling the incident, Dr. Gupta said, 'I saw people standing around someone on the ground. When I reached him, I realized he was sweating heavily and breathing just four times a minute,' Dr. Niraj recalled. 'It was a cardiac arrest, and we had to act quickly,' as quoted by The Khaleej Times.
As the hospital was nearby, Dr. Gupta wasted no time and called for an ambulance and began CPR. The patient was given two shocks before reaching the hospital, followed by a third one, which was delivered inside the emergency department.
Live Events
Emergency, ICU, and cardiology teams acted swiftly, and a full Code Blue was activated at the hospital. Sasidharan was given treatment on priority. According to Khaleej Times, he was diagnosed with a critical cardiac condition, acute inferior wall ST-Elevation Myocardial Infarction (STEMI), and ventricular fibrillation (VF).
An angiography revealed a 100 percent blockage in the right coronary artery and a 90 percent blockage in the left. Four drug-eluting stents were placed to restore blood flow. He was able to walk again freely in just two days due to swift medical intervention.
Sasidharan thanks Dr Gupta after recovery
Following his recovery, Sasidharan said that he was not even aware that he was suffering from diabetes. He thanked Dr. Gupta for taking swift action, which saved his life.
'I didn't even know I had diabetes. I thought I was healthy. If the doctor hadn't been there at that moment, I wouldn't be alive today. I am just so thankful,' Sasidharan was quoted by The Khaleej Times as saying.
Sasidharan also said that the near-death experience has changed his life. 'I've cut down on junk food. I started walking every day, and I'm making health my top priority. I got a second chance; I won't take it for granted,' he said.
Dr Gupta reveals major reasons behind heart attacks in young adults
Dr. Niraj, who performed the entire procedure without pause, said poor lifestyle habits are one of the biggest contributors to heart attacks in young adults. 'People in their 30s shouldn't be experiencing this. But stress, poor diet, smoking, processed food, and high cholesterol are major risk factors,' he noted.
He requested residents to take regular checkups seriously and recommended basic heart screenings, including the Treadmill Test (TMT), Lipid profile, Blood sugar levels, and a CT scan of the heart.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
DGCA to form a committee to revise medical parameters for Indian pilots: Airline Pilots Association
NEW DELHI: Aviation regulator, the Directorate General of Civil Aviation (DGCA), has agreed to constitute a committee to revise medical parameters for pilots operating civilian aircraft in India. According to the Airline Pilots Association of India (ALPA), the revised standards would be in line with the recommendations of the International Civil Aviation Organisation (ICAO). This followed a grievance raised by the association that the mandatory medical evaluations done by the regulator's empanelled medical centres were inconsistent with the international body's recommendations. An official release said the committee's approval was one of the key outcomes of a meeting between ALPA and the regulator at its head office in New Delhi on Monday (July 14). ALPA, a Bengaluru-based organisation over two decades old, represents more than 1,000 Indian pilots working both in India and abroad. Last week, the association had rejected the findings of the probe into the Ahmedabad plane crash by the Aircraft Accidents Investigation Bureau (AAIB) and lashed out at the bias toward pilot error. As of now, the medical evaluations for civilian pilots are being carried out at the Institute of Aerospace Medicine in Bengaluru and the Air Force Central Medical Establishment of the Indian Air Force.
The Hindu
an hour ago
- The Hindu
BBMP to float tender for stray dog microchipping project, for third time
The Bruhat Bengaluru Mahanagara Palike (BBMP) is set to float a tender for the third time to microchip stray dogs, even as a charitable trust has moved the High Court to challenge the project. The matter is currently sub judice. According to the tender proposal, the project is estimated to cost ₹3.23 crore. Of this, ₹3.09 crore is allocated for procuring 1,62,817 microchips and ₹14.85 lakh is set aside for purchasing 50 microchip readers. A BBMP official overseeing the project explained that each microchip, measuring around 1–1.5 mm, will be injected into the first layer of a dog's skin near the neck using a hypodermic needle. This procedure will be carried out by specialists working under the Animal Birth Control (ABC) programme. As the official noted, the selected contractor will be required to procure the microchips, which are not manufactured in India, and also provide software for storing and managing the associated data. 'Procurement will take place in phases as we complete implanting the previously procured microchips. We will inform the contractor in advance, and they will be responsible for supplying the next batch,' the official told The Hindu, adding that while there is no fixed deadline, the project is expected to be completed within one or two years. The contractor is also required to provide software services, which the BBMP will access for free for a period of one year. After that, the contractor will submit an annual cost estimate, and the BBMP will subscribe accordingly. According to BBMP officials, only two known contractors, one from Gujarat and one from Mumbai, currently meet the eligibility criteria. Suralkar Vikas Kishor, Special Commissioner (Health and Animal Husbandry), BBMP, stated that the first tender, floated in February last year, received no bids. A second tender was issued later that year and awarded to a contractor, but he failed to meet the software service requirements specified in the tender. Meanwhile, the BBMP conducted a pilot project in which microchips were implanted in 500 stray dogs. An audit conducted 15 days later showed no adverse effects on the dogs, and the chips functioned effectively, according to Mr. Kishor. Each microchip will contain a GPS tracker and a Unique Identification Number (UIN), enabling BBMP officials to locate microchipped dogs. The UIN will store data, including vaccination details, the dog's location, and photographs, all of which will be stored on a server accessible via the software. Animal rights activist Arun Prasad called the project illegal. 'ABC rules do not permit the implantation of microchips in free-roaming stray dogs. They only allow private dog owners to microchip their pets for identification purposes,' said Mr. Prasad. A Bengaluru-based charitable trust has filed a Public Interest Litigation (PIL) in the High Court challenging the project. The case is currently under judicial consideration.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Emcure enters distribution agreement with Sanofi for diabetes drugs
Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes Emcure added that it will engage with healthcare professionals and expand the reach of these therapeutic solutions for patients across the country. Sanket Koul New Delhi Pune-based Emcure Pharmaceuticals on Wednesday announced an exclusive distribution and promotion agreement with Sanofi India (SIL) for its oral anti-diabetic (OAD) products in India. Under the agreement, SIL will continue to own and manufacture the brands across its plants in India and internationally, while Emcure will exclusively distribute and promote SIL's OAD range, which includes well-established brands such as Amaryl and Cetapin. There will be no employee transition from SIL to Emcure as part of this arrangement, the Pune-based drugmaker said in a regulatory filing to the exchanges. Emcure added that it will engage with healthcare professionals and expand the reach of these therapeutic solutions for patients across the country. 'With our strong distribution network in India, Sanofi's trusted oral anti-diabetic medicines will be available to more patients who need them,' he added. Over 100 million Indians are currently living with type 2 diabetes and its associated complications, according to a study by the Indian Council of Medical Research–INDIAB (India Diabetes). 'Of these, more than 60 per cent are living with uncontrolled blood sugar levels and are at higher risk of developing complications over time,' said Eric Mansion, general manager (pharma) for Southeast Asia and India at Sanofi. He added that with Emcure's wide and deeply penetrated presence across India, the company is confident of tapping the full growth potential of Amaryl and Cetapin. The announcement was made post market hours. On Wednesday, shares of Emcure Pharmaceuticals closed marginally higher by 0.22 per cent at Rs 1,363.85 apiece on the Bombay Stock Exchange (BSE).
